胰腺神经内分泌肿瘤（PNETs）的管理极具挑战性，其治疗方案需高度个体化。研究人员围绕 PNETs 的手术管理展开研究，综合分析多项研究成果。结果显示不同大小、功能的 PNETs 手术策略不同。这为临床治疗提供了重要依据，助力优化治疗方案。 在医学领域 ...

Two distinct subtypes discovered, each with dramatically different risks of recurrence Patients with more aggressive subtype can be monitored vigilantly for recurrence and possible treatment, while ...

SEATTLE -- Surgery for pancreatic neuroendocrine tumors (pNETs) significantly improved survival for all patients except those with the earliest-stage disease, a retrospective review of 4,700 patients ...

Effect of BPM 31510 on survival outcomes when used in combination with gemcitabine in a preclinical model of pancreatic cancer. Serum levels of macrophage inhibitory cytokine-1 (MIC1) and matrix ...

这篇研究通过回顾性分析287例胰腺神经内分泌肿瘤（pNETs）患者数据，建立了基于术前因素（如肿瘤位置、淋巴结肿大、远处转移等）的风险分层模型。研究证实，低风险患者（0-1个因素）淋巴结转移率仅9.5%，可避免不必要的淋巴结清扫（LN dissection）；而高风险 ...

A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may help predict recurrence of non-functional pancreatic neuroendocrine ...

Neuroendocrine tumors (NETs) are rare cancers that can arise in a number of different organs, particularly the gastrointestinal tract, lungs, and pancreas. The clinical course of these tumors can vary ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SEATTLE -- ...

Researchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors – known as pNETs – that have dramatically different risks of recurrence following surgical treatment [or surgery].

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma (ICC) and the effect of yttrium-90 (Y90) radioembolization: SEER versus tertiary cancer center. Second-line gemcitabine ...